Literature DB >> 29278275

Prevalence of and indications for antipsychotic use in Parkinson's disease.

James H Bower1, Brandon R Grossardt2, Walter A Rocca1,3, Rodolfo Savica1,3.   

Abstract

BACKGROUND: The prevalence of patients with PD taking antipsychotics is unknown.
OBJECTIVE: To measure the prevalence of patients with PD taking antipsychotics.
METHODS: We used the medical records-linkage system of the Rochester Epidemiology Project to study the use of antipsychotic medication in all persons with Parkinson disease in Olmsted County, Minnesota on 1 January 2006.
RESULTS: There were 296 patients with PD in Olmsted County on 1 January 2006. The overall prevalence of antipsychotic use was 9.8% (29 of 296); 95.5% (28 of 29) of the patients had dementia when initiating antipsychotics. The most frequent indication (71.4%; 20 of 28) was psychosis or behavior threatening to the patient or others.
CONCLUSIONS: The prevalence of antipsychotic use in patients with PD is lower than expected from previously reported cumulative incidences. Dementia is highly prevalent in those starting antipsychotics. Most of the patients on antipsychotics had a reasonable risk-benefit ratio for taking them.
© 2017 International Parkinson and Movement Disorder Society. © 2017 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Parkinson's disease; antipsychotics; dementia; prevalence

Mesh:

Substances:

Year:  2017        PMID: 29278275      PMCID: PMC5809193          DOI: 10.1002/mds.27256

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  14 in total

1.  Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project.

Authors:  Jennifer L St Sauver; Brandon R Grossardt; Cynthia L Leibson; Barbara P Yawn; L Joseph Melton; Walter A Rocca
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

2.  Antipsychotics and mortality in Parkinsonism.

Authors:  Connie Marras; Andrea Gruneir; Xuesong Wang; Hadas Fischer; Sudeep S Gill; Nathan Herrmann; Geoffrey M Anderson; Christopher Hyson; Paula A Rochon
Journal:  Am J Geriatr Psychiatry       Date:  2012-02       Impact factor: 4.105

3.  Incidence, prescription patterns, and determinants of antipsychotic use in patients with Parkinson's disease.

Authors:  Meng-Ting Wang; Pei-Wen Lian; Chin-Bin Yeh; Che-Hung Yen; Kao-Hsing Ma; Agnes L F Chan
Journal:  Mov Disord       Date:  2011-05-31       Impact factor: 10.338

4.  Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system.

Authors:  Jennifer L St Sauver; Brandon R Grossardt; Barbara P Yawn; L Joseph Melton; Joshua J Pankratz; Scott M Brue; Walter A Rocca
Journal:  Int J Epidemiol       Date:  2012-11-18       Impact factor: 7.196

5.  Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990.

Authors:  J H Bower; D M Maraganore; S K McDonnell; W A Rocca
Journal:  Neurology       Date:  1999-04-12       Impact factor: 9.910

6.  Patterns and trends in antipsychotic prescribing for Parkinson disease psychosis.

Authors:  Daniel Weintraub; Peijun Chen; Rosalinda V Ignacio; Eugenia Mamikonyan; Helen C Kales
Journal:  Arch Neurol       Date:  2011-07

7.  Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project.

Authors:  Jennifer L St Sauver; Brandon R Grossardt; Barbara P Yawn; L Joseph Melton; Walter A Rocca
Journal:  Am J Epidemiol       Date:  2011-03-23       Impact factor: 4.897

8.  A 12-year population-based study of psychosis in Parkinson disease.

Authors:  Elin B Forsaa; Jan Petter Larsen; Tore Wentzel-Larsen; Christopher G Goetz; Glenn T Stebbins; Dag Aarsland; Guido Alves
Journal:  Arch Neurol       Date:  2010-08

9.  Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism.

Authors:  Rodolfo Savica; Brandon R Grossardt; James H Bower; J Eric Ahlskog; Walter A Rocca
Journal:  JAMA Neurol       Date:  2013-07       Impact factor: 18.302

10.  Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease.

Authors:  Daniel Weintraub; Claire Chiang; Hyungjin Myra Kim; Jayne Wilkinson; Connie Marras; Barbara Stanislawski; Eugenia Mamikonyan; Helen C Kales
Journal:  JAMA Neurol       Date:  2016-05-01       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.